Showing 1,041 - 1,060 results of 2,046 for search '"kinase"', query time: 0.06s Refine Results
  1. 1041

    Multimodal Imaging of Neural Progenitor Cell Fate in Rodents by Yannic Waerzeggers, Markus Klein, Hrvoje Miletic, Uwe Himmelreich, Hongfeng Li, Parisa Monfared, Ulrich Herrlinger, Mathias Hoehn, Heinrich Hubert Coenen, Michael Weller, Alexandra Winkeler, Andreas Hans Jacobs

    Published 2008-03-01
    “…We investigated C17.2 cells stably expressing herpes simplex virus type 1–thymidine kinase (HSV-1- tk ) and green fluorescent protein ( gfp ) (C17.2- tk IRES gfp = C17.2-TIG) or HSV-1- tk , gfp , and firefly luciferase ( luc ) (C17.2- luc IRES tkgfp = C17.2-LITG) and determined the detection sensitivity of positron emission tomography (PET) and bioluminescence imaging (BLI) for these cells in culture and in vivo in subcutaneous and intracranial glioma models. …”
    Get full text
    Article
  2. 1042

    Oleuropein Improves Cognitive Dysfunction and Neuroinflammation in Diabetic Rats through the PI3K/Akt/mTOR Pathway by Jianru Shang, Shan Che, Mingjie Zhu

    Published 2022-01-01
    “…Additionally, the malondialdehyde (MDA), myeloperoxidase (MPO) content, superoxide dismutase (SOD) activity, interleukin- (IL-) 1β, tumor necrosis factor (TNF-α), and phosphatidylinositol 3-kinases (PI3K)/threonine-protein kinase (Akt)/mTOR expression levels in rat hippocampus tissues were detected. …”
    Get full text
    Article
  3. 1043

    Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation by John S. Wang, Omar Elghawy, Brett R. Kurpiel, Michael G. Douvas

    Published 2022-01-01
    “…After clinical progression, he was treated with sorafenib, a multiprotein kinase inhibitor more commonly used in the treatment of hepatocellular and renal cell carcinoma due to its off target FLT3 inhibition. …”
    Get full text
    Article
  4. 1044

    Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury by Zhu Y, Xu G

    Published 2025-02-01
    “…Corresponding targeted medications such as Abatacept, chemokine receptor (CCR) inhibitors, CDDO-Im (2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide), adenosine monophosphate-activated protein kinase (AMPK) activators, and Adalimumab are currently under investigation. …”
    Get full text
    Article
  5. 1045

    Investigation of a Biochemical Model with Recycling in Case of Negative Cooperativity by Svetoslav G. Nikolov, Vassil M. Vassilev, Momchil I. Nenov

    Published 2025-01-01
    “…The objective of this paper is to find new dynamic perspectives in a well-known two dimensional nonlinear system which is a modification of the phosphofructo kinase model by incorporating recycling of the product, <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi>p</mi></semantics></math></inline-formula>, into the substrate, <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi>s</mi></semantics></math></inline-formula>. …”
    Get full text
    Article
  6. 1046

    Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma by Martina Napolitano, Lucia Trudu, Enrica Martinelli, Chiara Santini, Massimo Dominici, Federica Bertolini

    Published 2025-01-01
    “…After progression on first line chemotherapy, was administered neratinib, a pan‐Erb2 receptor tyrosine kinase inhibitor. Even with central nervous system involvement at diagnosis, a durable clinical response was obtained with a PFS of 11 months and no significant toxicities to manage. …”
    Get full text
    Article
  7. 1047

    Effect of Transcutaneous Electrical Acupoint Stimulation on BUN, Serum T and Serum CK-MM Concentrations in College Athletes with High-level Football Match by Shoujiang LI, Jiapeng LI, Xiangjia KONG, Yong HU, Shijing YOU

    Published 2018-06-01
    “…Objective:To observe the impact of the transcutaneous electrical acupoint stimulation (TEAS) on blood urea nitrogen (BUN),serum testosterone (T) and serum creatine kinase isoenzyme-MM (CK-MM) of college athletes in high-level football match.Methods:Twenty-four college football players were randomly divided into control group, Group 1 and Group 2,with eight athletes in each group. …”
    Get full text
    Article
  8. 1048

    Drug-induced bone disorders: A systematic review by Anshita Aggarwal, Meha Sharma, Indira Maisnam, Soumitra Ghosh, Sameer Aggarwal, Saptarshi Bhattacharya, Deep Dutta

    Published 2019-01-01
    “…Anti-epileptics, proton pump inhibitors, glucocorticoids, immunosuppressants (calcineurin inhibitors), anticoagulants, glitazones, SGLT2 inhibitors, somatostatin analogs, anticancer medications, and protein kinase inhibitors are some of the commonly used medications associated with bone mineral loss. …”
    Get full text
    Article
  9. 1049

    Identification of key regulators in pancreatic ductal adenocarcinoma using network theoretical approach. by Kankana Bhattacharjee, Aryya Ghosh

    Published 2025-01-01
    “…Our analysis revealed 33 key regulators were predominantly enriched in neuroactive ligand-receptor interaction, Cell adhesion molecules, Leukocyte transendothelial migration pathways; positive regulation of cell proliferation, positive regulation of protein kinase B signaling biological functions; G-protein beta-subunit binding, receptor binding molecular functions etc. …”
    Get full text
    Article
  10. 1050

    Adenosine deficiency facilitates CA1 synaptic hyperexcitability in the presymptomatic phase of a knockin mouse model of Alzheimer disease by Mattia Bonzanni, Alice Braga, Takashi Saito, Takaomi C. Saido, Giuseppina Tesco, Philip G. Haydon

    Published 2025-01-01
    “…Both pharmacologic (adenosine kinase inhibitor) and non-pharmacologic (ketogenic diet) restorations of the adenosine tone successfully normalize hippocampal neuronal activity. …”
    Get full text
    Article
  11. 1051

    Nonprofessional Phagocytosis Can Facilitate Herpesvirus Entry into Ocular Cells by Vaibhav Tiwari, Deepak Shukla

    Published 2012-01-01
    “…Similar inhibition was seen by blocking phosphoinositide 3 kinase signaling, which is required for microbial phagocytosis. …”
    Get full text
    Article
  12. 1052

    Differential Gene Expression Profile of Human Neutrophils Cultured with Plasmodium falciparum-Parasitized Erythrocytes by Mohamad Alaa Terkawi, Ryo Takano, Kentaro Kato

    Published 2018-01-01
    “…Gene enrichment analysis suggested that the biological pathways involved in the PMN responses to the iRBCs included insulin receptor, Jak-STAT signaling pathway, mitogen-activated protein kinase (MAPK), and interleukin and interferon-gamma (IFN-γ) signaling pathways. …”
    Get full text
    Article
  13. 1053

    Physiological and pathophysiological actions of insulin in the liver by Naoto Kubota, Tetsuya Kubota, Takashi Kadowaki

    Published 2025-02-01
    “…Insulin receptor signaling regulates glycogenesis, gluconeogenesis and lipogenesis through downstream pathways such as the insulin receptor substrate (IRS)-phosphoinositide 3 (PI3) kinase-Akt pathway. IRS-1 and IRS-2 are abundantly expressed in the liver and are thought to be responsible for transmitting the insulin signal from the insulin receptor to the intracellular effectors involved in the regulation of glucose and lipid homeostasis. …”
    Get full text
    Article
  14. 1054

    PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors by Francesco Dituri, Antonio Mazzocca, Gianluigi Giannelli, Salvatore Antonaci

    Published 2011-01-01
    “…The phosphatidylinositol 3-kinase (PI3K) pathway regulates multiple cellular processes which underlie immune responses against pathogens or malignant cells. …”
    Get full text
    Article
  15. 1055

    A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges by Erica di Martino, Darren C. Tomlinson, Margaret A. Knowles

    Published 2012-01-01
    “…Fibroblast growth factors (FGFs) orchestrate a variety of cellular functions by binding to their transmembrane tyrosine-kinase receptors (FGFRs) and activating downstream signalling pathways, including RAS/MAPK, PLCγ1, PI3K, and STATs. …”
    Get full text
    Article
  16. 1056

    Nobiletin Decreases Inflammatory Mediator Expression in Tumor Necrosis Factor-Stimulated Human Periodontal Ligament Cells by Yoshitaka Hosokawa, Ikuko Hosokawa, Kazumi Ozaki

    Published 2021-01-01
    “…Moreover, we revealed that nobiletin could inhibit the activation of nuclear factor- (NF-) κB and protein kinase B (AKT1) pathways in TNF-stimulated HPDLCs. …”
    Get full text
    Article
  17. 1057

    The Effect of Alcoholic Extract of Anabasis syriaca Iljin on Biochemical and Histological Parameters in Rats by Suad M. Kloub, Saleem A. Banihani, Omar M. Atrooz, Wael M. Hananeh

    Published 2022-01-01
    “…Among all tested biochemical parameters, a significant increase was noted in fasting serum glucose (p≤0.010), troponin (p≤0.001), and creatine kinase (p≤0.001), while a significant decrease was found in triglycerides (p≤0.001) and low-density lipoprotein (p=0.001). …”
    Get full text
    Article
  18. 1058

    Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs by Xiang Zhang, Yulian Yin, Qiuting Yu, Xinlin Chen, Yiqin Cheng

    Published 2025-02-01
    “…In this paper, we classify them into three categories: monoclonal antibodies (mAbs), small-molecule tyrosine kinase inhibitors (TKIs), and antibody-drug conjugate (ADCs). …”
    Get full text
    Article
  19. 1059

    Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation by Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen

    Published 2018-01-01
    “…Allogeneic stem cell transplantation (allo-SCT) was considered the first-line treatment for CML, before the introduction of tyrosine kinase inhibitors (TKIs). However, patients are at risk for relapse years after transplantation. …”
    Get full text
    Article
  20. 1060

    Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment by Gregory W. Charville, Sukhmani K. Padda, Richard K. Sibley, Ajithkumar Puthillath, Paul Y. Kwo

    Published 2018-01-01
    “…We discuss the case of a 26-year-old female with a history of ROS1-rearranged lung adenocarcinoma, undergoing treatment with the tyrosine kinase inhibitor crizotinib, who presented to our hospital with abdominal pain and scleral icterus. …”
    Get full text
    Article